179 related articles for article (PubMed ID: 36081393)
21. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.
Saad F; Caliber M; Doros G; Haider KS; Haider A
Aging Male; 2020 Mar; 23(1):81-92. PubMed ID: 30782054
[No Abstract] [Full Text] [Related]
22. Androgen replacement in men undergoing treatment for prostate cancer.
Rhoden EL; Averbeck MA; Teloken PE
J Sex Med; 2008 Sep; 5(9):2202-8. PubMed ID: 18638000
[TBL] [Abstract][Full Text] [Related]
23. Testosterone replacement therapy and the risk of prostate cancer.
Warburton D; Hobaugh C; Wang G; Lin H; Wang R
Asian J Androl; 2015; 17(6):878-81; discussion 880. PubMed ID: 25865848
[TBL] [Abstract][Full Text] [Related]
24. Testosterone and prostate cancer: revisiting old paradigms.
Isbarn H; Pinthus JH; Marks LS; Montorsi F; Morales A; Morgentaler A; Schulman C
Eur Urol; 2009 Jul; 56(1):48-56. PubMed ID: 19375844
[TBL] [Abstract][Full Text] [Related]
25. A rational approach to androgen therapy for hypogonadal men with prostate cancer.
Kaufman J
Int J Impot Res; 2006; 18(1):26-31. PubMed ID: 16208401
[TBL] [Abstract][Full Text] [Related]
26. Testosterone Therapy Among Prostate Cancer Survivors.
Nguyen TM; Pastuszak AW
Sex Med Rev; 2016 Oct; 4(4):376-88. PubMed ID: 27474995
[TBL] [Abstract][Full Text] [Related]
27. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.
Lopez DS; Huang D; Tsilidis KK; Khera M; Williams SB; Urban RJ; Panagiotou OA; Kuo YF; Baillargeon J; Farias A; Krause T
Clin Endocrinol (Oxf); 2019 Dec; 91(6):885-891. PubMed ID: 31498469
[TBL] [Abstract][Full Text] [Related]
28. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
Haider A; Zitzmann M; Doros G; Isbarn H; Hammerer P; Yassin A
J Urol; 2015 Jan; 193(1):80-6. PubMed ID: 24980615
[TBL] [Abstract][Full Text] [Related]
29. Testosterone Therapy in Advanced Prostate Cancer.
Chedrawe E; Sathe A; White J; Ory J; Ramasamy R
Androg Clin Res Ther; 2022; 3(1):180-186. PubMed ID: 36684061
[TBL] [Abstract][Full Text] [Related]
30. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review.
Shabsigh R; Crawford ED; Nehra A; Slawin KM
Int J Impot Res; 2009; 21(1):9-23. PubMed ID: 18633357
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
[TBL] [Abstract][Full Text] [Related]
33. Testosterone replacement therapy after primary treatment for prostate cancer.
Agarwal PK; Oefelein MG
J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
[TBL] [Abstract][Full Text] [Related]
34. Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.
Kaufman JM; Graydon RJ
J Urol; 2004 Sep; 172(3):920-2. PubMed ID: 15310998
[TBL] [Abstract][Full Text] [Related]
35. Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.
Balbontin FG; Moreno SA; Bley E; Chacon R; Silva A; Morgentaler A
BJU Int; 2014 Jul; 114(1):125-30. PubMed ID: 25101359
[TBL] [Abstract][Full Text] [Related]
36. Recurrence of prostate cancer in patients receiving testosterone supplementation for hypogonadism.
Gray H; Seltzer J; Talbert RL
Am J Health Syst Pharm; 2015 Apr; 72(7):536-41. PubMed ID: 25788507
[TBL] [Abstract][Full Text] [Related]
37. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer.
Kovac JR; Pan MM; Lipshultz LI; Lamb DJ
Steroids; 2014 Nov; 89():27-32. PubMed ID: 25072793
[TBL] [Abstract][Full Text] [Related]
38. Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.
Traish AM
Sex Med Rev; 2018 Jan; 6(1):86-105. PubMed ID: 29128268
[TBL] [Abstract][Full Text] [Related]
39. Testosterone therapy in the ageing male: what about the prostate?
Schultheiss D; Machtens S; Jonas U
Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
[TBL] [Abstract][Full Text] [Related]
40. Testosterone replacement therapy following the diagnosis of prostate cancer: outcomes and utilization trends.
Kaplan AL; Trinh QD; Sun M; Carter SC; Nguyen PL; Shih YT; Marks LS; Hu JC
J Sex Med; 2014 Apr; 11(4):1063-1070. PubMed ID: 24443943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]